𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of ligand binding assay and enzyme immunoassay of oestrogen receptor in human breast cancer cytosols

✍ Scribed by M. A. Blankenstein

Publisher
Springer US
Year
1990
Tongue
English
Weight
653 KB
Volume
17
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparison of sex steroid receptor deter
Comparison of sex steroid receptor determinations in human breast cancer by enzyme immunoassay and radioligand binding
✍ Resad Pasic; Benjamin Djulbegovic; James L. Wittliff πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 630 KB

Most investigators comparing ligand-binding procedures for quantifying estrogen and progestin receptors in human breast cancer with procedures employing monoclonal antibodybased methods have utilized an inappropriate variety of reaction conditions, including the elimination of sodium molybdate in th

Estrogen and progesterone receptors in b
Estrogen and progesterone receptors in breast cancer: Comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay
✍ Antonio Cavaliere; Emilio Bucciarelli; Angelo Sidoni; Giuseppina Bianchi; Nadia πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 453 KB πŸ‘ 2 views

Evaluation of estrogen (ER) and progesterone (PR) receptor content is now an important procedure in the management of breast cancer patients. Production of monoclonal antibodies to ER and PR has permitted development of an enzyme immunoassay (EIA) and immunocytochemical assay (ICA). This study compa

Comparison of radioligand assay and immu
Comparison of radioligand assay and immunostaining for epidermal growth factor receptor in human breast cancer
✍ D. J. Hastrich; J. M. Dunn; S. Nicholson; P. Newcomb; Professor J. R. Farndon πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 394 KB πŸ‘ 2 views

## Abstract Epidermal growth factor (EGF) receptor status is a useful prognostic indicator in women with breast cancer. Lack of standardization and correlation of methodology for the detection of EGF receptor has hampered its further evaluation. EGF receptor status was ascertained by immunohistoche